• 1
    Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179186.
  • 2
    Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 2006; 20:11591169.
  • 3
    Bradley SF. Prevention of influenza in long-term-care facilities. Long-Term-Care Committee of the Society for Healthcare Epidemiology of America. Infect Control Hosp Epidemiol 1999; 20:629637.
  • 4
    US Centers for Disease Control and Prevention. Interim guidance for influenza outbreak management in long-term care facilities. US Centers for Disease Control and Prevention. Available at Last Updated 2011 (Accessed 2 May 2012).
  • 5
    Arroyo JC, Postic B, Brown A, Harrison K, Birgenheier R, Dowda H. Influenza A/Philippines/2/82 outbreak in a nursing home: limitations of influenza vaccination in the aged. Am J Infect Control 1984; 12:329334.
  • 6
    Chang YM, Li WC, Huang CT et al. Use of oseltamivir during an outbreak of influenza A in a long-term care facility in Taiwan. J Hosp Infect 2008; 68:8387.
  • 7
    Coles FB, Balzano GJ, Morse DL. An outbreak of influenza A (H3N2) in a well immunized nursing home population. J Am Geriatr Soc 1992; 40:589592.
  • 8
    Infuso A, Baron S, Fauveau H, Melon M, Fleury H, Desenclos JC. Value of influenza vaccine during an outbreak of influenza A in a nursing home, Pyrenees Atlantiques, France, November-December 1995. Euro Surveill 1996; 1:3537.
  • 9
    Lee C, Loeb M, Phillips A et al. Zanamivir use during transmission of amantadine-resistant influenza A in a nursing home. Infect Control Hosp Epidemiol 2000; 21:700704.
  • 10
    Meiklejohn G, Hoffman R, Graves P. Effectiveness of influenza vaccine when given during an outbreak of influenza A/H3N2 in a nursing home. J Am Geriatr Soc 1989; 37:407410.
  • 11
    Murayama N, Suzuki H, Arakawa M, Nerome K, Mizuta K, Kameyama K. Two outbreaks of influenza A (H3N2) in a Japanese nursing home in the winter of 1996-1997, with differing vaccine efficacy. Tohoku J Exp Med 1999; 188:289298.
  • 12
    Parker R, Loewen N, Skowronski D. Experience with oseltamivir in the control of a nursing home influenza B outbreak. Can Commun Dis Rep 2001; 27:3740.
  • 13
    Seale H, Weston KM, Dwyer DE et al. The use of oseltamivir during an influenza B outbreak in a chronic care hospital. Influenza Other Resp Viruses 2009; 3:1520.
  • 14
    Staynor K, Foster G, McArthur M, McGeer A, Petric M, Simor AE. Influenza A outbreak in a nursing home: the value of early diagnosis and the use of amantadine hydrochloride. Can J Infect Control 1994; 9:109111.
  • 15
    Strassburg MA, Greenland S, Sorvillo FJ, Lieb LE, Habel LA. Influenza in the elderly: report of an outbreak and a review of vaccine effectiveness reports. Vaccine 1986; 4:3844.
  • 16
    Taylor JL, Dwyer DM, Coffman T, Groves C, Patel J, Israel E. Nursing home outbreak of influenza A (H3N2): evaluation of vaccine efficacy and influenza case definitions. Infect Control Hosp Epidemiol 1992; 13:9397.
  • 17
    Jefferson T, Demicheli V, Rivetti D, Jones M, Di PC, Rivetti A. Antivirals for influenza in healthy adults: systematic review. Lancet 2006; 367:303313.
  • 18
    Schilling M, Povinelli L, Krause P et al. Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks. Vaccine 1998; 16:17711774.
  • 19
    Monto AS, Ohmit SE, Hornbuckle K, Pearce CL. Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes. Antimicrob Agents Chemother 1995; 39:22242228.
  • 20
    Jefferson T, Rivetti D, Rivetti A, Rudin M, Di PC, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 2005; 366:11651174.
  • 21
    Booy R, Lindley RI, Dwyer DE et al. Treating and preventing influenza in aged care facilities: a cluster randomised controlled trial. PLoS ONE 2012; 7:e46509.
  • 22
    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097.
  • 23
    R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at (Accessed 16 May 2013).
  • 24
    Thomas A, O'Hara B, Ligges O, Sturtz S. Making BUGS Open. R News 2006; 6:1217.
  • 25
    US Centers for Disease Control and Prevention. Overview of influenza surveillance in the United States. US Centers for Disease Control and Prevention. Available at Last Updated 2011 (Accessed 15 June 2012).
  • 26
    Davies WL, Grunert RR, Haff RF et al. Antiviral activity of 1-adamantanamine (amantadine). Science 1964; 144:862863.
  • 27
    Peters NL, Oboler S, Hair C, Laxson L, Kost J, Meiklejohn G. Treatment of an influenza A outbreak in a teaching nursing home. Effectiveness of a protocol for prevention and control. J Am Geriatr Soc 1989; 37:210218.
  • 28
    Schilling M, Gravenstein S, Drinka P et al. Emergence and transmission of amantadine-resistant influenza A in a nursing home. J Am Geriatr Soc 2004; 52:20692073.
  • 29
    Arden NH, Patriarca PA, Fasano MB et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988; 148:865868.
  • 30
    Gaillat J, Dennetiere G, Raffin-Bru E, Valette M, Blanc MC. Summer influenza outbreak in a home for the elderly: application of preventive measures. J Hosp Infect 2008; 70:272277.
  • 31
    Bowles SK, Lee W, Simor AE et al. Use of oseltamivir during influenza outbreaks in Ontario nursing homes, 1999–2000. J Am Geriatr Soc 2002; 50:608616.
  • 32
    Bush KA, McAnulty J, McPhie K et al. Antiviral prophylaxis in the management of an influenza outbreak in an aged care facility. Commun Dis Intell 2004; 28:396400.
  • 33
    Babcock HM, Merz LR, Fraser VJ. Is influenza an influenza-like illness? Clinical presentation of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2006; 27:266270.
  • 34
    Babcock HM, Merz LR, Dubberke ER, Fraser VJ. Case-control study of clinical features of influenza in hospitalized patients. Infect Control Hosp Epidemiol 2008; 29:921926.
  • 35
    Thursky K, Cordova SP, Smith D, Kelly H. Working towards a simple case definition for influenza surveillance. J Clin Virol 2003; 27:170179.
  • 36
    Nichol KL. Heterogeneity of influenza case definitions and implications for interpreting and comparing study results. Vaccine 2006; 24:67266728.
  • 37
    Ferson MJ, Morgan K, Robertson PW, Hampson AW, Carter I, Rawlinson WD. Concurrent summer influenza and pertussis outbreaks in a nursing home in Sydney, Australia. Infect Control Hosp Epidemiol 2004; 25:962966.
  • 38
    Mathur U, Bentley DW, Hall CB. Concurrent respiratory syncytial virus and influenza A infections in the institutionalized elderly and chronically ill. Ann Intern Med 1980; 93:4952.
  • 39
    Goronzy JJ, Fulbright JW, Crowson CS, Poland GA, O'Fallon WM, Weyand CM. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001; 75:1218212187.
  • 40
    Jefferson T, Del Mar CB, Dooley L et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev 2011:CD006207.
  • 41
    Win MK, Chow A, Chen M, Lau YF, Ooi EE, Leo YS. Influenza B outbreak among influenza-vaccinated welfare home residents in Singapore. Ann Acad Med Singapore 2010; 39:448452.
  • 42
    Burette P, Bouuaert C, Melin P, Yane F, Brochier B, Giet D. Influenza outbreak in a well-vaccinated nursing home population in Belgium. Acta Clin Belg 2009; 64:324328.
  • 43
    Dindinaud G, Potiron G, Agius G et al. Influenza epidemic among a community of elderly people in spite of vaccination. Eur J Epidemiol 1993; 9:667670.
  • 44
    Drinka PJ, Gravenstein S, Krause P et al. Non-influenza respiratory viruses may overlap and obscure influenza activity. J Am Geriatr Soc 1999; 47:10871093.
  • 45
    Drinka PJ, Gravenstein S, Krause P, Nest L, Dissing M, Shult P. Reintroduction of influenza A to a nursing building. Infect Control Hosp Epidemiol 2000; 21:732735.
  • 46
    Drinka PJ, Haupt T. Emergence of rimantadine-resistant virus within 6 days of starting rimantadine prophylaxis with oseltamivir treatment of symptomatic cases. J Am Geriatr Soc 2007; 55:923926.
  • 47
    Goodman RA, Orenstein WA, Munro TF, Smith SC, Sikes RK. Impact of influenza A in a nursing home. JAMA 1982; 247:14511453.
  • 48
    Hall WN, Goodman RA, Noble GR, Kendal AP, Steece RS. An outbreak of influenza B in an elderly population. J Infect Dis 1981; 144:297302.
  • 49
    Horman JT, Stetler HC, Israel E, Sorley D, Schipper MT, Joseph JM. An outbreak of influenza A in a nursing home. Am J Public Health 1986; 76:501504.
  • 50
    Libow LS, Neufeld RR, Olson E, Breuer B, Starer P. Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine. J Am Geriatr Soc 1996; 44:11531157.
  • 51
    Mast EE, Harmon MW, Gravenstein S et al. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2). Am J Epidemiol 1991; 134:988997.
  • 52
    Surya P, Influenza A outbreaks–Louisiana, August 1993. MMWR Morb Mortal Wkly Rep 1993; 42:689692.
  • 53
    Morens DM, Rash VM. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol 1995; 16:275280.
  • 54
    Oguma T, Saito R, Masaki H et al. Molecular characteristics of outbreaks of nosocomial infection with influenza A/H3N2 virus variants. Infect Control Hosp Epidemiol 2011; 32:267275.
  • 55
    Read CA, Mohsen A, Nguyen-Van-Tam JS, McKendrick M, Kudesia G. Outbreaks of influenza A in nursing homes in Sheffield during the 1997–1998 season: implications for diagnosis and control. J Public Health Med 2000; 22:116120.
  • 56
    Degelau J, Somani SK, Cooper SL, Guay DR, Crossley KB. Amantadine-resistant influenza A in a nursing facility. Arch Intern Med 1992; 152:390392.